Thymic Epithelial Cell-Derived IL-15 and IL-15 Receptor α Chain Foster Local Environment for Type 1 Innate Like T Cell Development

被引:8
|
作者
Tao, Huishan [1 ]
Li, Lei [1 ]
Liao, Nan-Shih [2 ]
Schluns, Kimberly S. [3 ]
Luckhart, Shirley [4 ]
Sleasman, John W. [1 ]
Zhong, Xiao-Ping [1 ,5 ,6 ]
机构
[1] Duke Univ, Med Ctr, Dept Pediat Allergy & Immunol, Durham, NC 27710 USA
[2] Acad Sinica, Inst Mol Biol, Taipei, Taiwan
[3] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA
[4] Univ Idaho, Dept Biol Sci, Dept Entomol Plant Pathol & Nematol, Moscow, ID 83843 USA
[5] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA
[6] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC 27710 USA
来源
FRONTIERS IN IMMUNOLOGY | 2021年 / 12卷
基金
美国国家卫生研究院;
关键词
IL-15; IL-15Rα thymic epithelial cells; iNKT cells; γ δ T cells; type 1 innate like T cells; INVARIANT NKT CELLS; SELF-ANTIGEN EXPRESSION; NATURAL-KILLER; GENE-EXPRESSION; INTRATHYMIC DEVELOPMENT; NEGATIVE SELECTION; TRANS-PRESENTATION; TIGHT REGULATION; INKT CELLS; MEDULLA;
D O I
10.3389/fimmu.2021.623280
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Expression of tissue-restricted antigens (TRAs) in thymic epithelial cells (TECs) ensures negative selection of highly self-reactive T cells to establish central tolerance. Whether some of these TRAs could exert their canonical biological functions to shape thymic environment to regulate T cell development is unclear. Analyses of publicly available databases have revealed expression of transcripts at various levels of many cytokines and cytokine receptors such as IL-15, IL-15R alpha, IL-13, and IL-23a in both human and mouse TECs. Ablation of either IL-15 or IL-15R alpha in TECs selectively impairs type 1 innate like T cell, such as iNKT1 and gamma delta T1 cell, development in the thymus, indicating that TECs not only serve as an important source of IL-15 but also trans-present IL-15 to ensure type 1 innate like T cell development. Because type 1 innate like T cells are proinflammatory, our data suggest the possibility that TEC may intrinsically control thymic inflammatory innate like T cells to influence thymic environment.
引用
收藏
页数:12
相关论文
共 40 条
  • [31] BCL11B depletion induces the development of highly cytotoxic innate T cells out of IL-15 stimulated peripheral blood αβ CD8+T cells
    Forkel, Hannes
    Grabarczyk, Piotr
    Depke, Maren
    Troschke-Meurer, Sascha
    Simm, Stefan
    Hammer, Elke
    Michalik, Stephan
    Hentschker, Christian
    Corleis, Bjoern
    Loyal, Lucie
    Zumpe, Maxi
    Siebert, Nikolai
    Dorhoi, Anca
    Thiel, Andreas
    Lode, Holger
    Voelker, Uwe
    Schmidt, Christian A.
    ONCOIMMUNOLOGY, 2022, 11 (01):
  • [32] IL-15 Prevents the Development of T-ALL from Aberrant Thymocytes with Impaired DNA Repair Functions and Increased NOTCH1 Activation
    Nandi, Madhuparna
    Ghosh, Amit
    Akbari, Sara Ali
    Bobbala, Diwakar
    Boucher, Marie-Josee
    Menendez, Alfredo
    Hoang, Trang
    Ilangumaran, Subburaj
    Ramanathan, Sheela
    CANCERS, 2023, 15 (03)
  • [33] IL-15 transpresentation by ovarian cancer cells improves CD34+ progenitor-derived NK cell's anti-tumor functionality
    Vidal-Manrique, M.
    Nieuwenstein, T.
    Hooijmaijers, L.
    de Jonge, P. K. J. D.
    Djojoatmo, M.
    Jansen, J.
    van der Waart, A. B.
    Brock, R.
    Dolstra, H.
    ONCOIMMUNOLOGY, 2025, 14 (01):
  • [34] Monocytes and T cells cooperate to favor normal and follicular lymphoma B-cell growth: role of IL-15 and CD40L signaling
    Epron, G.
    Ame-Thomas, P.
    Le Priol, J.
    Pangault, C.
    Dulong, J.
    Lamy, T.
    Fest, T.
    Tarte, K.
    LEUKEMIA, 2012, 26 (01) : 139 - 148
  • [35] Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: Multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal
    Tamang, David L.
    Redelman, Doug
    Alves, Bryce N.
    Vollger, Leanne
    Bethley, Christy
    Hudig, Dorothy
    CYTOKINE, 2006, 36 (3-4) : 148 - 159
  • [36] Cytotoxic CD4 development requires CD4 effectors to concurrently recognize local antigen and encounter type I IFN-induced IL-15
    Devarajan, Priyadharshini
    Vong, Allen M.
    Castonguay, Catherine H.
    Silverstein, Noah J.
    Kugler-Umana, Olivia
    Bautista, Bianca L.
    Kelly, Karen A.
    Luban, Jeremy
    Swain, Susan L.
    CELL REPORTS, 2023, 42 (10):
  • [37] Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4+T Cell
    Sun, Li
    Wang, Qianqian
    Chen, Bin
    Zhao, Yuanyuan
    Shen, Bo
    Wang, Xinlong
    Zhu, Miaolin
    Li, Zhuqian
    Zhao, Xiangdong
    Xu, Changgen
    Chen, Zhihong
    Wang, Mei
    Xu, Wenrong
    Zhu, Wei
    STEM CELLS AND DEVELOPMENT, 2018, 27 (17) : 1203 - 1214
  • [38] IL-2 And IL-15 Induced NKG2D, CD158a and CD158b Expression on T, NKT- like and NK Cell Lymphocyte Subsets from Regional Lymph Nodes of Melanoma Patients
    Vuletic, Ana
    Jovanic, Irena
    Jurisic, Vladimir
    Milovanovic, Zorka
    Nikolic, Srdan
    Spurnic, Igor
    Konjevic, Gordana
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) : 223 - 231
  • [39] Augmented IL-15Rα Expression by CD40 Activation Is Critical in Synergistic CD8 T Cell-Mediated Antitumor Activity of Anti-CD40 Antibody with IL-15 in TRAMP-C2 Tumors in Mice
    Zhang, Meili
    Ju, Wei
    Yao, Zhengsheng
    Yu, Ping
    Wei, Bih-Rong
    Simpson, R. Mark
    Waitz, Rebecca
    Fasso, Marcella
    Allison, James P.
    Waldmann, Thomas A.
    JOURNAL OF IMMUNOLOGY, 2012, 188 (12) : 6156 - 6164
  • [40] ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial
    Wrangle, John M.
    Velcheti, Vamsidhar
    Patel, Manish R.
    Garrett-Mayer, Elizabeth
    Hill, Elizabeth G.
    Ravenel, James G.
    Miller, Jeffrey S.
    Farhad, Mohammad
    Anderton, Kate
    Lindsey, Kathryn
    Taffaro-Neskey, Michele
    Sherman, Carol
    Suriano, Samantha
    Swiderska-Syn, Marzena
    Sion, Amy
    Harris, Joni
    Edwards, Andie R.
    Rytlewski, Julie A.
    Sanders, Catherine M.
    Yusko, Erik C.
    Robinson, Mark D.
    Krieg, Carsten
    Redmond, William L.
    Egan, Jack O.
    Rhode, Peter R.
    Jeng, Emily K.
    Rock, Amy D.
    Wong, Hing C.
    Rubinstein, Mark P.
    LANCET ONCOLOGY, 2018, 19 (05) : 694 - 704